Alnylam Pharmaceuticals | ALNY - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
BioCryst Pharmaceuticals USD 171.59M 164.32M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Moderna USD 1.91B 687M 2026-03
Neurocrine Biosciences USD 266.5M 446.5M 2026-03
Novartis USD 9.56B 2.9B 2025-09
PTC Therapeutics USD 833.99M 150.66M 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Takeda JPY 654.94B 26.55B 2025-12
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Xencor USD 14.17M 39.9M 2026-03